391 related articles for article (PubMed ID: 1891788)
1. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial.
Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G
Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788
[TBL] [Abstract][Full Text] [Related]
2. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: a prospective, randomized trial.
van Marwijk Kooy M; van Prooijen HC; Moes M; Bosma-Stants I; Akkerman JW
Blood; 1991 Jan; 77(1):201-5. PubMed ID: 1984797
[TBL] [Abstract][Full Text] [Related]
3. A prospective, randomized study of the use of platelet concentrates irradiated with ultraviolet-B light in patients with hematologic malignancy.
Blundell EL; Pamphilon DH; Fraser ID; Menitove JE; Greenwalt TJ; Snyder EL; Repucci AJ; Hedberg SL; Anderson JK; Buchholz DH; Kagen LR; Aster RH
Transfusion; 1996 Apr; 36(4):296-302. PubMed ID: 8623127
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte-depleted blood components prevent platelet refractoriness in patients with acute myeloid leukemia.
Oksanen K
Eur J Haematol; 1994 Aug; 53(2):100-7. PubMed ID: 8088380
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: a randomized prospective study.
Sintnicolaas K; van Marwijk Kooij M; van Prooijen HC; van Dijk BA; van Putten WL; Claas FH; Novotny VM; Brand A
Blood; 1995 Feb; 85(3):824-8. PubMed ID: 7833483
[TBL] [Abstract][Full Text] [Related]
6. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
7. Prevention of refractoriness and HLA-alloimmunization using filtered blood products.
Sniecinski I; O'Donnell MR; Nowicki B; Hill LR
Blood; 1988 May; 71(5):1402-7. PubMed ID: 3282572
[TBL] [Abstract][Full Text] [Related]
8. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
9. Clinical aspects of platelet transfusions.
Murphy MF; Waters AH
Blood Coagul Fibrinolysis; 1991 Apr; 2(2):389-96. PubMed ID: 1893071
[TBL] [Abstract][Full Text] [Related]
10. The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients.
Saris A; Kerkhoffs JL; Norris PJ; van Ham SM; Ten Brinke A; Brand A; van der Meer PF; Zwaginga JJ
Transfusion; 2019 Feb; 59(2):470-481. PubMed ID: 30499599
[TBL] [Abstract][Full Text] [Related]
11. Bedside filtration of blood products in the prevention of HLA alloimmunization--a prospective randomized study. Alloimmunisation Study Group.
Williamson LM; Wimperis JZ; Williamson P; Copplestone JA; Gooi HC; Morgenstern GR; Norfolk DR
Blood; 1994 May; 83(10):3028-35. PubMed ID: 8180400
[TBL] [Abstract][Full Text] [Related]
12. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
Murphy MF; Metcalfe P; Thomas H; Eve J; Ord J; Lister TA; Waters AH
Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
Schiffer CA; Dutcher JP; Aisner J; Hogge D; Wiernik PH; Reilly JP
Blood; 1983 Oct; 62(4):815-20. PubMed ID: 6349715
[TBL] [Abstract][Full Text] [Related]
14. Development of white blood cell fragments, during the preparation and storage of platelet concentrates, as measured by using real-time polymerase chain reaction.
Dijkstra-Tiekstra MJ; van der Schoot CE; Pietersz RN; Huijgens PC; van der Meer PF; Reesink HW
Vox Sang; 2004 Nov; 87(4):250-6. PubMed ID: 15585020
[TBL] [Abstract][Full Text] [Related]
15. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group.
Kao KJ; Mickel M; Braine HG; Davis K; Enright H; Gernsheimer T; Gillespie MJ; Kickler TS; Lee EJ; McCullough JJ
Transfusion; 1995 Jan; 35(1):13-9. PubMed ID: 7998062
[TBL] [Abstract][Full Text] [Related]
16. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
[TBL] [Abstract][Full Text] [Related]
17. Refractoriness to platelet transfusions in children with acute leukemia.
DeCoteau J; Haddad S; Blanchette V; Poon A
J Pediatr Hematol Oncol; 1995 Nov; 17(4):306-10. PubMed ID: 7583385
[TBL] [Abstract][Full Text] [Related]
18. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial.
Hess JR; Trachtenberg FL; Assmann SF; Triulzi DJ; Kaufman RM; Strauss RG; Granger S; Slichter SJ
Vox Sang; 2016 Oct; 111(3):281-291. PubMed ID: 27185561
[TBL] [Abstract][Full Text] [Related]
19. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration.
Andreu G; Dewailly J; Leberre C; Quarre MC; Bidet ML; Tardivel R; Devers L; Lam Y; Soreau E; Boccaccio C
Blood; 1988 Sep; 72(3):964-9. PubMed ID: 3416079
[TBL] [Abstract][Full Text] [Related]
20. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components.
Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC
Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
